LUNGevity Foundation Launches Innovative Research Award
The LUNGevity Foundation is excited to announce its inaugural Mid-Career "Bridge to Breathe" Research Award, aimed at supporting and retaining mid-career researchers in the field of lung cancer. This initiative highlights the foundation's commitment to promoting ongoing research and ensuring that talented individuals remain active in this critical area of oncology.
The Need for Mid-Career Support in Research
Research data reveals a concerning trend: many mid-career researchers, particularly in the realm of cancer studies, struggle to secure funding after their initial grant. Statistics indicate that nearly 45% of cancer researchers do not succeed in obtaining subsequent funding six years post their first major research grant. This funding gap not only hinders their professional growth but also leads to a drastic reduction in experienced researchers dedicated to lung cancer.
Details on the 'Bridge to Breathe' Award
The newly established LUNGevity Foundation 2025 Mid-Career "Bridge to Breathe" Research Award is specifically designed for researchers between 5 to 15 years into their faculty careers. The awarded funding, which totals up to $150,000 over two years, aims to advance essential research focused on early detection and individualized treatments for lung cancer.
Application Process and Timeline
To apply, candidates must start by submitting a letter of intent (LOI), which is due soon. Following this initial stage, selected applicants will be invited to submit a comprehensive application by the specified deadline. This two-step process ensures that the most promising research proposals receive support.
Impacts of the Award
This award provides a crucial lifeline for talented researchers, encouraging them to continue their vital work in the field. By investing in mid-career professionals, LUNGevity aims to promote innovation and growth, ultimately leading to better outcomes for patients living with lung cancer.
Mission and Vision of LUNGevity Foundation
LUNGevity Foundation holds a prominent position as a leading organization focused on lung cancer. The organization's mission is to improve the quality of life for lung cancer patients and survivors while striving for health equity across the healthcare system.
Research Commitment
Through innovative research efforts, LUNGevity emphasizes the importance of early detection and the development of new treatment methods. The foundation's efforts contribute to a robust pipeline of new investigators who will shape the future of lung cancer research.
Advocacy and Community Engagement
By advocating for increased access to screening and treatment, LUNGevity facilitates collaborations that can revolutionize patient care. In addition, they offer education and support to those affected by lung cancer, ensuring that individuals have access to the resources they need.
About Lung Cancer in the United States
Lung cancer remains a critical health concern, with about 1 in 18 Americans being diagnosed during their lifetime. Despite the increasing number of diagnoses, many patients are still unaware of their heightened risks, especially given that an estimated 65% of new diagnoses occur in individuals with no significant tobacco exposure.
Statistics and Survival Rates
The disease takes more lives than the next two most deadly cancers combined. However, early detection significantly improves survival rates, highlighting the need for continued research and innovative treatment modalities.
Frequently Asked Questions
What is the 'Bridge to Breathe' Research Award?
The award is a new initiative by LUNGevity Foundation aimed at supporting mid-career researchers in lung cancer research.
Who can apply for this award?
Mid-career researchers within 5 to 15 years of their first faculty appointment are eligible to apply.
How much funding will be awarded?
A maximum funding of $150,000 is available over a two-year period for selected research projects.
When is the application deadline?
The letter of intent (LOI) is due on February 14, 2025, and full applications are due by May 12, 2025.
What are the goals of the research projects?
Research projects should aim to create methods for early detection and personalized treatment for lung cancer, with high-risk proposals encouraged.
